Links are not yet activated.
Is this your press release? Add a link to submitpr.org on your website and verify it — activation is instant and free.
Or upgrade with KIN for permanent activation (from $19.95).
SHENZHEN, China — October 8, 2026 — CURORI has outlined a set of follow-up questions for international users to resolve with the treating doctor and licensed institution before returning home after medical-aesthetic or cosmetic treatment in China.Travel planning should include more than an appointment date. Before departure, a patient should understand how long the provider recommends remaining locally, whether an in-person review is required, which records or instructions will be supplied and how to contact the responsible clinical team after leaving China.
The follow-up plan should identify expected review dates, wound or treatment-area care where applicable, medicine instructions, activity or travel restrictions, and symptoms that require prompt medical attention. Those details must come from the qualified treating provider and should reflect the individual's procedure and assessment.
International users can also ask which photographs, reports or other updates the provider may request during remote follow-up, which communication channel should be used and what response times are normally available. Routine questions and urgent concerns may require different contacts.
“Follow-up should be discussed before travel becomes fixed, not only when the patient is preparing to leave,” said Jiani Peng, founder of CURORI. “The responsible provider should explain the clinical plan, while coordination can help keep contact and practical information organized.”
CURORI may help arrange communication, interpretation, appointment reminders or practical local support, subject to availability. It does not monitor a patient's condition, provide emergency medical services or replace the treating doctor's instructions. If urgent medical assistance is needed, the patient should contact appropriate local emergency or medical services and inform the treating provider.
A useful departure checklist may include the doctor's and institution's contact details, a copy of the treatment summary when available, the medicine list, planned review schedule, restrictions relevant to flying or other travel, remote follow-up instructions and the process for sharing new information securely.
Users should also clarify what follow-up is included in the clinical quotation and what services may carry a separate fee. A lower initial treatment figure may not include the same review schedule or remote support as another proposal. Final inclusions must be confirmed by the treating institution.
When another clinician in the home country may be involved, the patient can ask what records should be carried or requested and how the China-based provider can be contacted for relevant clinical information. Availability and documentation practices vary by provider and procedure.
Founded in 2025, CURORI is a China Hospital Alliance and Doctor Network for international users researching and comparing medical-aesthetic and cosmetic-treatment options in China.
CURORI is not a hospital, clinic or treating medical provider. Qualified doctors and licensed medical institutions remain responsible for treatment, recovery instructions, risk disclosure, follow-up and decisions about urgent or ongoing care.
More information is available at https://curori.com.